| 1. |
1 Cook GJ, Houston S, Rubens R,
et al . Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol , 1998, 16(10): 3375-3379.
|
| 2. |
Whiting PF, Weswood ME, Rutjes AW, et al . Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol , 2006, 6: 9.
|
| 3. |
馬章淳, 錢楠, 譯. QUADAS評價: 一種用于診斷性研究的質量評價工具(修訂版). 中國循證醫學雜志, 2007, 7(7): 531-536.
|
| 4. |
Devillé WL, Buntinx F, Bouter LM, et al . Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol , 2002, 2: 9.
|
| 5. |
Krüger S, Buck AK, Mottaghy FM, et al . Detection of bone metastases in patients with lung cancer: 99mTc-MDP planar bone scintigraphy, 18F-fluoride PET or 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging , 2009, 36(11): 1807-1812.
|
| 6. |
Min JW, Um SW, Yim JJ, et al . The role of whole-body FDG PET/CT, Tc 99m MDP bone scintigraphy, and serum alkaline phosphatase in detecting bone metastasis in patients with newly diagnosed lung cancer. J Korean Med Sci , 2009, 24(2): 275-280.
|
| 7. |
Even-Sapir E, Metser U, Mishani E, et al . The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. J Nucl Med , 2006, 47(2): 287-297.
|
| 8. |
Song JW, Oh YM, Shim TS, et al . Efficacy comparison between (18)F-FDG PET/CT and bone scintigraphy in detecting bony metastases of non-small-cell lung cancer. Lung Cancer , 2009, 65(3): 333-338.
|
| 9. |
Lavely W, Jacene H, Leal J, et al . Comparative performance of FDG PET/CT and Tc-99m bone scintigraphy for detecting and localizing bone metastases in patients with breast cancer. European Joural of Cardio-thoracic Surgery , 2010, 37(4): 792-796.
|
| 10. |
Steinborn MM, Heuck AF, Tiling R, et al . Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr , 1999, 23(1): 123-129.
|
| 11. |
Sedonja I, Budihna NV. The benefit of SPECT when added to planar scintigraphy in patients with bone metastases in the spine. Clin Nucl Med , 1999, 24(6): 407-413.
|
| 12. |
Cook GJ, Houston S, Rubens R, et al . Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol , 1998, 16(10): 3375-3379.
|
| 13. |
Uematsu T, Yuen S, Yukisawa S, et al . Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer. AJR Am J Roentgenol , 2005, 184(4): 1266-1273.
|
| 14. |
Liu FY, Chang JT, Wang HM, et al . [18F]fluorodeoxyglucose positron emission tomography is more sensitive than skeletal scintigraphy for detecting bone metastasis in endemic nasopharyngeal carcinoma at initial staging. J Clin Oncol , 2006, 24(4): 599-604.
|
| 15. |
Mijnhout GS, Riphagen II, Hoekstra OS. Update of the FDG PET search strategy. Nucl Med Commun , 2004, 25(12): 1187-1189.
|
| 16. |
Schmid RA, Hautmann H, Poellinger B, et al . Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique(hybrid PET). Nucl Med Commun , 2003, 24(1): 37-45.
|
| 17. |
Dwamena BA, Sonnad SS, Angobaldo JO, et al . Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. Radiology , 1999, 213(2): 530-536.
|
